As of April 25, 2025, Clearside Biomedical (CLSD) has a market cap of $65.046 million USD. According to our data, Clearside Biomedical is ranked No.7922 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 25, 2025 | $65.05 M |
-9.72%
|
Dec 31, 2024 | $72.05 M |
-18.80%
|
Dec 29, 2023 | $88.74 M |
4.46%
|
Dec 30, 2022 | $84.94 M |
-59.27%
|
Dec 31, 2021 | $0.21 B |
0.36%
|
Dec 31, 2020 | $0.21 B |
-5.52%
|
Dec 31, 2019 | $0.22 B |
171.03%
|
Dec 31, 2018 | $81.15 M |
-84.71%
|
Dec 29, 2017 | $0.53 B |
-21.70%
|
Dec 30, 2016 | $0.68 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Regeneron Pharmaceuticals
REGN
|
$65.88 B |
1.095 B
|
![]() USA
|
![]() Alimera Sciences
ALIM
|
$0.30 B |
0.000 M
|
![]() USA
|
![]() EyePoint Pharmaceuticals
EYPT
|
$0.44 B |
0.000 M
|
![]() USA
|
![]() Bausch Health
BHC
|
$2.01 B |
-0.000 M
|
![]() Canada
|
![]() Novartis
NVS
|
$221.49 B |
-0.001 M
|
![]() Switzerland
|
![]() Pfizer
PFE
|
$130.09 B |
-0.003 M
|
![]() USA
|
![]() Kala Pharmaceuticals
KALA
|
$20.52 M |
0.000 M
|
![]() USA
|
![]() Adverum Biotechnologies
ADVM
|
$60.79 M |
0.000 M
|
![]() USA
|
![]() Ocular Therapeutix
OCUL
|
$1.23 B |
0.000 M
|
![]() USA
|
![]() Kodiak Sciences
KOD
|
$0.22 B |
0.000 M
|
![]() USA
|
![]() Ginkgo Bioworks
DNA
|
$0.45 B |
95.845 M
|
![]() USA
|
Market Cap | = | CLSD Stock Price | * | CLSD Shares Outstanding |
= | $0.84 | * | 77.28 M | |
= | $65.05 M |